Stephens analyst Scott Fidel lowered the firm’s price target on Cigna (CI) to $380 from $410 and keeps an Overweight rating on the shares. The ...

The villains were injectable specialty drugs like Keytruda and inpatient surgical procedures for seriously ill patients.

I had been out traveling I recently just got a job with benefits and skipped the dental insurance because I thought I was still getting billed. Come to find out Cigna ended the plan and sent me a ...